Daniel Motto

Chief Operating Officer at Enalare Therapeutics Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Princeton, JE
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • Enalare Therapeutics Inc.
    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Chief Operating Officer
      • 2020 - 3 years

      Princeton, New Jersey, United States Enalare Therapeutics is a clinical stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life threatening acute respiratory depression and critical care conditions.

  • Hikma Pharmaceuticals
    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Executive Vice President, US Injectables
      • Feb 2018 - Jan 2020

      Eatontown, New Jersey US injectables division of Hikma. Responsibilities included Sales, Marketing, Commercial Operations (contracts, customer service), Portfolio Management and Business Development.

  • Teva Pharmaceuticals
    • Israel
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • SVP, Global Business Development, Portfolio Management, Business Intelligence & Biosimilars
      • Aug 2016 - Nov 2017

      Parsippany, NJ Joined Teva when the company acquired the Actavis generics business from Allergan in August 2016. Member of executive leadership team for Teva Global Generic Medicines, leading key global functions including Business Development, Portfolio Management, Business Intelligence and Biosimilars.

  • Allergan
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • SVP, Global Business Development, Portfolio Management, Business Intelligence & Biosimilars
      • May 2010 - Aug 2016

      Parsippany, NJ Held a series of roles with expanding responsibilities during the transformation of the company from Watson Labs, to Actavis, to Allergan. Built a leading portfolio of >300 new product opportunities, including many high-value first-to-market PIV patent challenges. Executed on licensing deals with worldwide partners to build a pipeline for commercial operations in more than 80 countries, while supporting an aggressive M&A agenda that executed over $100 Billion in transactions.

  • Novartis
    • Switzerland
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Sandoz, Office of the CEO/Portfolio Management, US Region
      • Jun 2006 - May 2010

      Princeton, NJ Assistant to the US CEO, Head of Portfolio & Project Management

  • Johnson & Johnson
    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Multiple roles, CNS at Janssen Ortho McNeil
      • May 2003 - Jun 2006

      Titusville, NJ Positions included finance, marketing analysis, licensing and acquisitions supporting the innovative CNS Division at J&J.

  • Capital One
    • United States
    • Financial Services
    • 700 & Above Employee
    • Business Analyst - Marketing Strategy for Prime Markets
      • Aug 1999 - Aug 2001

      Richmond, VA

  • The Hart Partners
    • Consultant - Environmental Engineering & Management
      • Sep 1997 - Aug 1999

      Bethesda, MD

Education

  • Cornell University - Johnson Graduate School of Management
    Master of Business Administration (M.B.A.), Business Administration and Management, General
    2001 - 2003
  • Cornell University College of Engineering
    Master of Science study, Civil & Environmental Engineering
    1995 - 1997
  • Rutgers University-New Brunswick
    Bachelor of Science (BS) Degree, Environmental Science
    1990 - 1995

Community

You need to have a working account to view this content. Click here to join now